1. Home
  2. LEU vs SPRY Comparison

LEU vs SPRY Comparison

Compare LEU & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEU
  • SPRY
  • Stock Information
  • Founded
  • LEU 1998
  • SPRY 2015
  • Country
  • LEU United States
  • SPRY United States
  • Employees
  • LEU N/A
  • SPRY N/A
  • Industry
  • LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • SPRY Biotechnology: Pharmaceutical Preparations
  • Sector
  • LEU Industrials
  • SPRY Health Care
  • Exchange
  • LEU Nasdaq
  • SPRY Nasdaq
  • Market Cap
  • LEU 1.3B
  • SPRY 1.2B
  • IPO Year
  • LEU 1998
  • SPRY N/A
  • Fundamental
  • Price
  • LEU $53.05
  • SPRY $12.65
  • Analyst Decision
  • LEU Strong Buy
  • SPRY Strong Buy
  • Analyst Count
  • LEU 5
  • SPRY 4
  • Target Price
  • LEU $143.40
  • SPRY $28.75
  • AVG Volume (30 Days)
  • LEU 547.9K
  • SPRY 2.0M
  • Earning Date
  • LEU 05-06-2025
  • SPRY 03-20-2025
  • Dividend Yield
  • LEU N/A
  • SPRY N/A
  • EPS Growth
  • LEU N/A
  • SPRY N/A
  • EPS
  • LEU 4.47
  • SPRY 0.08
  • Revenue
  • LEU $442,000,000.00
  • SPRY $89,149,000.00
  • Revenue This Year
  • LEU $2.45
  • SPRY $41.49
  • Revenue Next Year
  • LEU $17.65
  • SPRY $80.23
  • P/E Ratio
  • LEU $12.89
  • SPRY $166.38
  • Revenue Growth
  • LEU 38.04
  • SPRY 297063.34
  • 52 Week Low
  • LEU $33.51
  • SPRY $7.55
  • 52 Week High
  • LEU $122.95
  • SPRY $18.51
  • Technical
  • Relative Strength Index (RSI)
  • LEU 29.17
  • SPRY 58.93
  • Support Level
  • LEU $60.65
  • SPRY $11.85
  • Resistance Level
  • LEU $68.19
  • SPRY $13.22
  • Average True Range (ATR)
  • LEU 4.33
  • SPRY 0.98
  • MACD
  • LEU -0.99
  • SPRY 0.09
  • Stochastic Oscillator
  • LEU 2.18
  • SPRY 55.02

About LEU Centrus Energy Corp.

Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: